Article Correctness Is Author's Responsibility: Standard of care chemoradiation for Stage III NSCLC is superior to two tested alternatives

(NRG Oncology) Lung cancer is the leading cause of cancer death in the United States and approximately 75-80% of all cases are non-small cell lung cancer (NSCLC). Of these, 30-40% are considered locally advanced and are categorized as either Stage IIIA or IIIB.